Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HALO | NUVL | KYMR | ||
| Company | Halozyme Therapeutic | Nuvalent Cl A | Kymera Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 77.85 | 123.57 | 115.06 | ||
| High | 79.51 | 123.80 | 115.47 | ||
| Low | 77.54 | 123.57 | 109.28 | ||
| Latest | 79.45 | 123.73 | 113.51 | ||
| Change | +2.44 | +0.13 | -0.69 | ||
| % Change | +3.17% | +0.11% | -0.60% | ||
| Volume | 1,566,200 | 1,297,500 | 788,300 | ||
| 20-Day Average Volume | 1,855,460 | 5,255,735 | 1,308,125 | ||
| Previous Close | 77.01 | 123.60 | 114.20 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 72.17 | 118.61 | 93.71 | ||
| 20-Day Raw Stochastic | 99.52% | 99.81% | 71.18% | ||
| 20-Day Relative Strength | 68.01 | 64.08 | 69.57 | ||
| Weighted Alpha | +44.94 | +32.41 | +134.97 | ||
| Today's Opinion | 72% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 56% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 56% Sell | 8% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +9.38% since 06/25/26 | +0.16% since 06/25/26 | -2.53% since 06/25/26 | ||
| Low | 72.71 on 06/26/26 | 123.43 on 06/30/26 | 105.00 on 06/29/26 | ||
| High | 79.51 on 07/02/26 | 123.80 on 07/02/26 | 119.04 on 06/26/26 | ||
| 1-Month | |||||
| %Chg | +19.87% since 06/02/26 | +35.45% since 06/02/26 | +59.22% since 06/02/26 | ||
| Low | 66.00 on 06/03/26 | 87.30 on 06/08/26 | 69.48 on 06/03/26 | ||
| High | 79.51 on 07/02/26 | 123.80 on 07/02/26 | 130.05 on 06/25/26 | ||
| 3-Month | |||||
| %Chg | +23.20% since 04/02/26 | +17.36% since 04/02/26 | +32.92% since 04/02/26 | ||
| Low | 62.27 on 04/07/26 | 87.30 on 06/08/26 | 69.48 on 06/03/26 | ||
| High | 79.51 on 07/02/26 | 123.80 on 07/02/26 | 130.05 on 06/25/26 | ||
| 6-Month | |||||
| %Chg | +13.00% since 01/02/26 | +22.70% since 01/02/26 | +56.01% since 01/02/26 | ||
| Low | 61.33 on 03/27/26 | 87.30 on 06/08/26 | 66.21 on 01/20/26 | ||
| High | 82.22 on 02/09/26 | 123.80 on 07/02/26 | 130.05 on 06/25/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 9,423,802 | 9,774,423 | 9,337,106 | ||
| Shares Outstanding, K | 118,613 | 78,998 | 82,258 | ||
| Annual Sales | 1,396,610,000 | 0 | 39,210,000 | ||
| Annual Net Income | 316,890,000 | -425,380,000 | -311,350,000 | ||
| Last Quarter Sales | 376,710,000 | 0 | 34,370,000 | ||
| Last Quarter Net Income | 150,050,000 | -109,280,000 | -69,230,000 | ||
| 60-Month Beta | 0.84 | 1.14 | 1.95 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.60 on 05/11/26 | -1.39 on 05/07/26 | -0.71 on 04/30/26 | ||
| Earnings Date | 08/04/26 | 08/06/26 | 08/10/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 18.21 | 0.00 | 0.00 | ||